ABS is Genetic Resources for Sustainable Development | ABSCH-VLR-SCBD-243431 | Virtual Library Resource | Access and Benefit-Sharing Clearing-House

PDF   |   Print   |  

Virtual Library Resource (VLR)

  published:05 Apr 2019

ABS is Genetic Resources for Sustainable Development
ABS is Genetic Resources for Sustainable Development highlights how 27 countries from Africa (6), Arab States (2), Asia (7), Central and Eastern Europe (2), Central America and The Caribbean (8) and Pacific Islands (2) are “investing in biodiversity for people and planet”. Assisted by the UNDP GEF Global ABS Project, these countries have articulated in writing very impressive cases of how they are exploring and harnessing the research, commercial and socio-economic benefits of genetic resources and traditional knowledge in compliance to the Convention on Biological Diversity and the Nagoya Protocol.
UNDP GEF Global ABS Project
- Organization: United Nations Development Programme (UNDP)
United Nations Development Programme (UNDP)
UN and other specialized agency of the UN Common System
New York,
United States of America
Phone: +1 (212) 906-6389,
  • Draft-10_Full-Cover22102018-1-704x1024.jpg
  • Book / Book chapter
Text document (e.g. adobe acrobat reader or Word)
  • Reference material/literature
  • Raising awareness
  • Civil society organizations
  • General public
  • Government
  • National/Federal
  • Sub-national
  • Indigenous people and local communities
  • Intergovernmental organization
  • Media
  • Private Sector
  • Research / Academia
  • Ex-situ collections
  • 16. Nagoya Protocol on ABS
  • Access to genetic resources (Article 15 of the CBD)
  • Key area 1: Capacity to implement and to comply with the obligation of the Protocol
  • Key area 2: Capacity to develop, implement and enforce domestic legislative, administrative or policy measures on access and benefit-sharing
  • Key area 3: Capacity to negotiate mutually agreed terms
  • Key area 4: Capacity needs and priorities of indigenous and local communities and relevant stakeholders, including the business sector and the research community
  • Key area 5: Capacity of countries to develop their endogenous research capabilities to add value to their own genetic resources
Additional Information